drugset / Trial / NCT00586898

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

NCT00586898

Phase 2 Completed 36 enrolled Memorial Sloan Kettering Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

Objective: To determine the response to rapid hormonal cycling in patients with non-castrate prostate cancer.

Timeline

Start
2001-07
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bicalutamide Other / unclassified
Subject Estradiol Other / unclassified Other
Subject Goserelin Other / unclassified
Subject Ketoconazole Small molecule
Subject Leuprolide Other / unclassified
Subject Testosterone Small molecule Other